The loss of libido can also be related to low testosterone levels, which may be remediable through supplementation with exogenous testosterone.

Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been shown to reduce the risk of worsening disease in people with heart failure and obesity in a phase 3 trial, the first to show a benefit on ...

At the time the licensing agreement was signed in October 2023, ocedurenone – an oral non-steroidal mineralocorticoid receptor antagonist (nsMRA) – was being tested in a phase 3 trial in ...

The primary naturally occurring mineralocorticoid is aldosterone – it’s primary function is the retention of salt. This is important because at higher levels, cortisol may also bind to ...

DNA adducts produced by exogenous and endogenous aldehydes are currently becoming recognized as potential tools for studying a variety of human diseases, as well as the effects of air pollution ...

According to Faubion and Shufelt, 10 the new generations of women will reach menopause with not only more freedom and safety to openly talk about the burden imposed by menopausal signs and symptoms, ...